Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 4 |
GO:0005737 | cytoplasm | 2 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HMV3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.477 |
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 134 | 136 | PF00675 | 0.373 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.480 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.533 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.456 |
CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.332 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.456 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.472 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.511 |
CLV_PCSK_PC1ET2_1 | 137 | 139 | PF00082 | 0.391 |
CLV_PCSK_PC1ET2_1 | 14 | 16 | PF00082 | 0.427 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.441 |
CLV_PCSK_PC7_1 | 109 | 115 | PF00082 | 0.453 |
CLV_PCSK_PC7_1 | 31 | 37 | PF00082 | 0.562 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.527 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.453 |
DOC_CKS1_1 | 96 | 101 | PF01111 | 0.435 |
DOC_MAPK_gen_1 | 132 | 142 | PF00069 | 0.445 |
DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.533 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.544 |
DOC_USP7_UBL2_3 | 101 | 105 | PF12436 | 0.505 |
DOC_USP7_UBL2_3 | 132 | 136 | PF12436 | 0.393 |
DOC_USP7_UBL2_3 | 137 | 141 | PF12436 | 0.393 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.421 |
DOC_USP7_UBL2_3 | 3 | 7 | PF12436 | 0.477 |
DOC_USP7_UBL2_3 | 9 | 13 | PF12436 | 0.483 |
DOC_WW_Pin1_4 | 95 | 100 | PF00397 | 0.431 |
LIG_14-3-3_CanoR_1 | 18 | 22 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 66 | 74 | PF00244 | 0.632 |
MOD_CDK_SPxK_1 | 95 | 101 | PF00069 | 0.433 |
MOD_CDK_SPxxK_3 | 95 | 102 | PF00069 | 0.439 |
MOD_GSK3_1 | 123 | 130 | PF00069 | 0.338 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.495 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.641 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.436 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.546 |
MOD_ProDKin_1 | 95 | 101 | PF00069 | 0.433 |
TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.363 |
TRG_NES_CRM1_1 | 86 | 97 | PF08389 | 0.365 |
TRG_NLS_MonoExtC_3 | 100 | 105 | PF00514 | 0.428 |
TRG_NLS_MonoExtN_4 | 135 | 140 | PF00514 | 0.336 |
TRG_NLS_MonoExtN_4 | 3 | 10 | PF00514 | 0.486 |
TRG_NLS_MonoExtN_4 | 99 | 105 | PF00514 | 0.524 |
TRG_Pf-PMV_PEXEL_1 | 6 | 10 | PF00026 | 0.468 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1S0 | Leptomonas seymouri | 74% | 100% |
A0A0S4JBT2 | Bodo saltans | 44% | 93% |
A0A1X0P5F8 | Trypanosomatidae | 53% | 96% |
A0A3Q8IIF2 | Leishmania donovani | 81% | 100% |
A0A3R7MVM6 | Trypanosoma rangeli | 51% | 100% |
A4IBH4 | Leishmania infantum | 80% | 100% |
C9ZZ68 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AFB0 | Leishmania major | 81% | 99% |
E9B6G5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |